We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors.
- Authors
van Essen, Martijn; Krenning, Eric P; Kam, Boen L R; de Herder, Wouter W; Feelders, Richard A; Kwekkeboom, Dik J
- Abstract
Regular therapy with the radiolabeled somatostatin analog (177)Lu-octreotate (22.2-29.6 GBq) in patients with gastroenteropancreatic or bronchial neuroendocrine tumors results in tumor remission in 46% of patients, including minor response. We present the effects of additional therapy with (177)Lu-octreotate in patients in whom progressive disease developed after an initial benefit from regular therapy.
- Publication
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Vol 51, Issue 3, p383
- ISSN
1535-5667
- Publication type
Journal Article
- DOI
10.2967/jnumed.109.068957